FDA publishes a list of off-patent, off-exclusivity drugs that have no generic alternatives to promote development of less expensive options for consu...
FDAs New Jersey District Office warns Raritan Pharmaceuticals about CGMP and other violations in its production of finished pharmaceuticals.
Federal Register notice: FDA seeks comments on an information collection extension for Medical Devices; Reports of Corrections and Removals 21 CFR Pa...
Attorney Stephen McConnell says a law review article properly faults FDAs position on truthful communication about off-label drug use.
FDA warns Adolfo Kaplan at the Pulmonary and Sleep Center of the Valley about objectionable conditions in the supervision and oversight of a clinical ...
The Securities and Exchange Commission files insider trading charges against two former employees and the spouse of a former employee of Ariad Pharmac...
FDA clears a Spineology 510(k) for the Rampart One Anterior Lumbar Interbody Fusion System.
Federal Register notice: FDA seeks comments on an information collection extension for Extralabel Drug Use in Animals 21 CFR Part 530 OMB Control Num...